Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Rini

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Research|August 9, 2003
The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patientsChiara Casati, Piero Dalerba, Licia Rivoltini, et al.
BMC Cancer|October 18, 2018
Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patientsChiara Camisaschi, Salvatore Lorenzo Renne, Valeria Beretta, et al.
BMC Cancer|April 17, 2015
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case reportMarcella Tazzari, Elena Palassini, Barbara Vergani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2020
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosisFederico Salomone, Salvatore Petta, Agnieszka Micek, et al.
Stem Cells (Dayton, Ohio)|June 15, 2016
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating CellsAlessandra Tuccitto, Marcella Tazzari, Valeria Beretta, et al.
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.
Atherosclerosis|February 1, 2020
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre studyLuigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani, et al.
Journal of Hepatology|March 6, 2018
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosisSalvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, et al.
Diabetes, Obesity & Metabolism|August 8, 2020
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective studyLuigi E Adinolfi, Salvatore Petta, Anna L Fracanzani, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|August 9, 2003
The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patientsChiara Casati, Piero Dalerba, Licia Rivoltini, et al.
BMC Cancer|October 18, 2018
Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patientsChiara Camisaschi, Salvatore Lorenzo Renne, Valeria Beretta, et al.
BMC Cancer|April 17, 2015
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case reportMarcella Tazzari, Elena Palassini, Barbara Vergani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2020
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosisFederico Salomone, Salvatore Petta, Agnieszka Micek, et al.
Stem Cells (Dayton, Ohio)|June 15, 2016
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating CellsAlessandra Tuccitto, Marcella Tazzari, Valeria Beretta, et al.
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.
Atherosclerosis|February 1, 2020
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre studyLuigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani, et al.
Journal of Hepatology|March 6, 2018
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosisSalvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, et al.
Diabetes, Obesity & Metabolism|August 8, 2020
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective studyLuigi E Adinolfi, Salvatore Petta, Anna L Fracanzani, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
Pageof 3